6th ‘W Dobrym Rytmie’ Conference

The 6th ‘W Dobrym Rytmie’ Conference took place on 6-7 November 2015 at the Narvil Hotel in Serock.

Friday, 6.11.2015

8:00 a.m. – 11:00 a.m. Registration of participants

9:30 a.m. – 11:00 a.m. Workshop: How and where to apply for research grants – J. Urbański

10:00 a.m. – 11:00 a.m. Session: Insight into the future of Cardiology – W. Toigo

11:00 a.m. – 12:30 p.m. 1st Session: Who does, who doesn’t?
Leads: K. Bieganowska, D. Czarnecka

1. Who should undergo genetic testing? – K. Biernacka
2. Sudden death of a family member as a risk factor for heart rhythm disturbances – M. Grabowski
3. Which patients with ventricular tachycardia don’t receive an ICD? – W. Mojkowski
4. Which patients with paroxysmal atrial fibrillation can’t undergo ablation? – P. Derejko

1:00 p.m. – 2:30 p.m. 2nd Session: Treat effectively but do no harm – PRIMUM NON NOCERE. The practice of using dabigatran in atrial fibrillation
Leads: K.J. Filipiak, B. Wożakowska-Kapłon

1. New possibilities to stop bleedings and reversing the effects of dabigatran – B. Wożakowska-Kapłon
2. New clinical data on the safety of NOAC – K.J. Filipiak
3. Haemorrhagic complications after NOAC as seen by other specialists: neurologist – A. Słowik, haematologist – A. Mital

2:30 p.m. – 3:30 p.m. Lunch

3:30 p.m. – 5:00 p.m. 3rd Session: Atrial fibrillation: Facts and myths (pro-contra)
Leads: R. Ochotny, G. Opolski

1. Before cardioversion, I always perform a transesophageal echocardiography
   Pro – W. Banasiak, Contra – Z. Kalarus
2. Should a patient after atrial fibrillation ablation receive oral anticoagulants?
   Pro – M. Trusz-Gluza, Contra – A. Lubiński

5:30 p.m. – 7:00 p.m. 4th Session: My patient with… what do I do?
Leads: A. Przybylski, E. Lewicka

1. A patient after ICD implantation with lead-dependent infective endocarditis – what do I do (in Polish conditions)? – A. Maciąg
2. My patient after ICD implantation with a decreased electrode signal strength and/or increase in stimulation threshold – K. Krzyżanowski
3. My patient after ICD implantation loses consciousness (and there is no significant ventricular arrhythmia in its memory) – J. Kuśnierz
4. My patient with an ICD requires MRI imaging (what is the reliability of the image) – A. Bissinger
5. My patient with Acute Coronary Syndrome and a fraction of 40% has experienced VT/VF – M. Kempa

7:00 p.m. – 7:30 p.m. Opening ceremony of the conference

7:00 p.m. 50 years of electrotherapy in Central Clinical Hospital in Warsaw – G. Opolski

8:30 p.m. Dinner

Saturday, 7.11.2015

9:00 a.m. – 10:30 a.m. 5th Session: Ablation of heart rate disturbances
Leads: J. Kaźmierczak, Ł. Szumowski

1. Are we ready for ablation in persistent atrial fibrillation? – O. Kowalski
2. Early and delayed complications of atrial fibrillation – how to recognise and treat them? – P. Kułakowski
3. Ablation in idiopathic ventricular arrhythmia – E. Koźluk
4. Principles of monitoring the effectiveness of ablation – A. Fuglewicz

11:00 a.m. – 12:30 p.m. 6th Session: Challenges of CRT therapy
Leads: D. Jagielski, K. Mizia-Stec

1. Interpretation of reported episodes of atrial fibrillation from implantable devices and remote monitoring devices and the impact on thromboembolic risk – M.Mazurek
2. Electrocardiographic exponents of effective resynchronisation – D. Wojciechowski
3. Tools for successful CRT implantation – a new approach to an old problem – M. Biffi
4. aCRT – let’s improve nature only where necessary – P. Mitkowski

1:00 p.m. – 2:30 p.m. 7th Session: What’s new in the guidelines and expert consensus
Leads: R. Piotrowicz, P. Ptaszyński

1. Treatment of electrotherapy complications – A. Filipecki
2. Expert consensus on ICD programming and testing – P. Syska
3. Expert consensus on the monitoring of cardiac implantable devices – Ł. Kołtowski
4. Ventricular arrhythmias and SCA – J. Bednarek

2:30 p.m. – 3:00 p.m. Summary and closing of the conference